These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 33375430)

  • 1. Nutritional Support in Head and Neck Radiotherapy Patients Considering HPV Status.
    Brewczyński A; Jabłońska B; Mrowiec S; Składowski K; Rutkowski T
    Nutrients; 2020 Dec; 13(1):. PubMed ID: 33375430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of human papillomavirus and p16 status with mucositis and dysphagia for head and neck cancer patients treated with radiotherapy with or without cetuximab: Assessment from a phase 3 registration trial.
    Bonner JA; Giralt J; Harari PM; Baselga J; Spencer S; Bell D; Raben D; Liu J; Schulten J; Ang KK; Rosenthal DI
    Eur J Cancer; 2016 Sep; 64():1-11. PubMed ID: 27323346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of HPV status on weight loss and feeding tube use in oropharyngeal carcinoma.
    Vangelov B; Kotevski DP; Williams JR; Smee RI
    Oral Oncol; 2018 Apr; 79():33-39. PubMed ID: 29598948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Human Papillomavirus and p16 Status With Outcomes in the IMCL-9815 Phase III Registration Trial for Patients With Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated With Radiotherapy With or Without Cetuximab.
    Rosenthal DI; Harari PM; Giralt J; Bell D; Raben D; Liu J; Schulten J; Ang KK; Bonner JA
    J Clin Oncol; 2016 Apr; 34(12):1300-8. PubMed ID: 26712222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does Human Papillomavirus Infection Influence the Frequency and Severity of Nutritional Disorders in Head and Neck Cancer?
    Mazurek M; Mlak R; Kot A; Rahnama-Hezavah M; Małecka-Massalska T
    Nutrients; 2022 Oct; 14(21):. PubMed ID: 36364788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of human papillomavirus on the prognosis and treatment of oropharyngeal carcinoma.
    Fung N; Faraji F; Kang H; Fakhry C
    Cancer Metastasis Rev; 2017 Sep; 36(3):449-461. PubMed ID: 28812214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subgroup Analysis According to Human Papillomavirus Status and Tumor Site of a Randomized Phase II Trial Comparing Cetuximab and Cisplatin Combined With Radiation Therapy for Locally Advanced Head and Neck Cancer.
    Buglione M; Maddalo M; Corvò R; Pirtoli L; Paiar F; Lastrucci L; Stefanacci M; Belgioia L; Crociani M; Vecchio S; Bonomo P; Bertocci S; Borghetti P; Pasinetti N; Triggiani L; Costa L; Tonoli S; Grisanti S; Magrini SM
    Int J Radiat Oncol Biol Phys; 2017 Mar; 97(3):462-472. PubMed ID: 27986347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastrostomy vs nasogastric tube feeding in patients with head and neck cancer during radiotherapy alone or combined chemoradiotherapy.
    Soria A; Santacruz E; Vega-Piñeiro B; Gión M; Molina J; Villamayor M; Mateo R; Riveiro J; Nattero L; Botella-Carretero JI
    Nutr Hosp; 2017 Jun; 34(3):512-516. PubMed ID: 28627183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of cisplatin dose intensity on human papillomavirus-related and -unrelated locally advanced head and neck squamous cell carcinoma.
    Spreafico A; Huang SH; Xu W; Granata R; Liu CS; Waldron JN; Chen E; Ringash J; Bayley A; Chan KK; Hope AJ; Cho J; Razak AA; Hansen A; Jang R; Perez-Ordonez B; Weinreb I; Bossi P; Orlandi E; Licitra LF; Song Y; O'Sullivan B; Siu LL; Kim J
    Eur J Cancer; 2016 Nov; 67():174-182. PubMed ID: 27669504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in the treatment of human papillomavirus-associated oropharyngeal carcinoma in Slovakia.
    Švajdová M; Dubinský P; Jeremić B; Vojtek V; Barilíková G; Selingerová I; Kazda T
    Neoplasma; 2024 Aug; 71(4):402-413. PubMed ID: 39267541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nutritional interventions in head and neck cancer patients undergoing chemoradiotherapy: a narrative review.
    Bossola M
    Nutrients; 2015 Jan; 7(1):265-76. PubMed ID: 25569622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The changing face of head and neck cancer: are patients with human papillomavirus-positive disease at greater nutritional risk? A systematic review.
    Edwards A; Brown T; Hughes BGM; Bauer J
    Support Care Cancer; 2022 Sep; 30(9):7191-7204. PubMed ID: 35477809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Did the addition of concurrent chemotherapy to conventional radiotherapy improve survival for patients with HPV+ve and HPV-ve Oropharynx cancer? A population-based study.
    Hall SF; Liu FF; O'Sullivan B; Shi W; Rohland S; Griffiths R; Groome P
    Br J Cancer; 2017 Oct; 117(8):1105-1112. PubMed ID: 28829763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastrostomy tube placement in patients with oropharyngeal carcinoma treated with radiotherapy or chemoradiotherapy: factors affecting placement and dependence.
    Bhayani MK; Hutcheson KA; Barringer DA; Lisec A; Alvarez CP; Roberts DB; Lai SY; Lewin JS
    Head Neck; 2013 Nov; 35(11):1634-40. PubMed ID: 23322563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient-reported outcomes in terms of swallowing and quality of life after prophylactic versus reactive percutaneous endoscopic gastrostomy tube placement in advanced oropharyngeal cancer patients treated with definitive chemo-radiotherapy: Swall PEG study.
    Dragan T; Van Gossum A; Duprez F; Lalami Y; Lefebvre Y; Mootassim-Billah S; Beauvois S; Gulyban A; Vandekerkhove C; Boegner P; Paesmans M; Ameye L; Digonnet A; Quiriny M; Dequanter D; Lipski S; Willemse E; Rodriguez A; Carlot S; Karaca Y; Lemort M; Emonts P; Al Wardi C; Van Gestel D
    Trials; 2022 Dec; 23(1):1036. PubMed ID: 36539781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nutritional counselling and oral nutritional supplements in head and neck cancer patients undergoing chemoradiotherapy.
    Valentini V; Marazzi F; Bossola M; Miccichè F; Nardone L; Balducci M; Dinapoli N; Bonomo P; Autorino R; Silipigni S; Giuliani F; Tamanti C; Mele MC; Martorana GE
    J Hum Nutr Diet; 2012 Jun; 25(3):201-8. PubMed ID: 22257023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic impact of HPV-associated p16-expression and smoking status on outcomes following radiotherapy for oropharyngeal cancer: The MARCH-HPV project.
    Lassen P; Lacas B; Pignon JP; Trotti A; Zackrisson B; Zhang Q; Overgaard J; Blanchard P;
    Radiother Oncol; 2018 Jan; 126(1):107-115. PubMed ID: 29100700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postoperative Treatment of Oropharyngeal Cancer in the Era of Human Papillomavirus.
    Geiger JL; Ku JA
    Curr Treat Options Oncol; 2019 Feb; 20(3):20. PubMed ID: 30771020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Manifestations of Human Papillomavirus in the Head and Neck.
    Dable C; Nicolli E
    Med Clin North Am; 2021 Sep; 105(5):849-858. PubMed ID: 34391538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oropharyngeal cancer - is it time to change management according to human papilloma virus status?
    Mehanna H; Olaleye O; Licitra L
    Curr Opin Otolaryngol Head Neck Surg; 2012 Apr; 20(2):120-4. PubMed ID: 22327790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.